ClinicalTrials.govpublic full text
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
advanced differentiated thyroid gland carcinoma, advanced head and neck carcinoma, advanced hepatocellular carcinoma, advanced kaposi sarcoma, advanced lung non-small cell carcinoma, advanced lung small cell carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 426781
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.